EichorEICHOR
Study identifier: NCT03621254 Synced from ClinicalTrials.gov · August 04, 2026
● Recruiting

Investigation Into Optimal FES Training Characteristics After Spinal Cord Injury

Condition: Spinal Cord Injury  ·  Sponsor: Swiss Paraplegic Research, Nottwil

PhaseNA
Planned participants20
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The aim of this study is to investigate two different modalities of functional electrical stimulation (FES) leg exercise in patients with spinal cord injury (SCI). The primary outcomes being compared are 1. FES-induced leg aerobic fitness, and 2. FES-induced leg strength. There will be two FES-leg training groups, and sub-acute patients with SCI will be randomised between the groups - high-short \[HI-SHORT\] and low-long \[LO-LONG\]. Both groups (n=10 per group) will exercise on the Hasomed RehaStim™ exercise ergometer for 6-8 weeks, three-four times per week (24 therapy sessions). \[HI-SHORT\] will perform 10 x 2-min of high-intensity interval training with a recovery of 1-2 min between exercise bouts. \[LO-LONG\] will perform 20+ min of continuous exercise at a low-moderate exercise intensity. Exercise intensity for \[HI-SHORT\] and \[LO-LONG\] will be titrated by neuromuscular stimulation characteristics. The primary outcomes will be assessed before training commences and after 6-8 weeks of training has been completed.

This description comes directly from the study's public registry record.

Talk to the study team

Ines Bersch, PhD  ·  +41 41 939 42 06  ·  ines.bersch@paraplegie.ch

Kathrin Schafer, MPH  ·  +41 41 939 43 34  ·  kathrin.schafer@paraplegie.ch

Always discuss trial participation with your own doctor first.

Locations (1)

Swiss Paraplegic CentreNottwil, Canton of Lucerne, SwitzerlandRecruiting

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →